Medtronic Inc. (MDT)

MDT (NYSE:Health Services)
$58.55
pos +0.00
+0.00%
Today's Range: 58.18 - 59.24 | MDT Avg Daily Volume: 5,093,900
Last Update: 04/17/14 - 4:01 PM EDT
Volume: 0
YTD Performance: 2.02%
Open: $0.00
Previous Close: $58.49
52 Week Range: $45.39 - $62.90
Oustanding Shares: 1,000,814,792
Market Cap: 58,597,706,072
6-Month Chart
TheStreet Ratings Grade for MDT
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 8 8 8
Moderate Buy 0 0 0 0
Hold 11 10 10 10
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.22 2.11 2.11 2.11
Latest Dividend: 0.28
Latest Dividend Yield: 1.87%
Dividend Ex-Date: 04/02/14
Price Earnings Ratio: 17.00
Price Earnings Comparisons:
MDT Sector Avg. S&P 500
17.00 16.60 29.08
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-1.61% 26.32% 42.63%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.50 0.05 0.02
Net Income -4.10 0.12 0.04
EPS -1.20 0.21 0.07
Earnings for MDT:
EBITDA 5.80B
Revenue 16.59B
Average Earnings Estimates
Qtr (04/14) Qtr (07/14) FY (04/14) FY (04/15)
Average Estimate $1.12 $0.94 $3.82 $4.09
Number of Analysts 13 7 14 13
High Estimate $1.13 $0.95 $3.83 $4.14
Low Estimate $1.12 $0.92 $3.81 $4.03
Prior Year $1.10 $0.88 $3.75 $3.82
Growth Rate (Year over Year) 2.03% 6.98% 1.85% 7.15%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Sell into the pop as the good news is set.
Bearish
Apr 14, 2014 | 8:14 AM EDT
MDT was downgraded from Overweight to Neutral, JP Morgan said. $64 price target. CoreValve injunction adds significant risk to the mode...
The stock is retreating from overbought levels, and it has upside catalysts ahead.
Bullish
Jan 06, 2014 | 8:32 AM EST
MDT was upgraded from Neutral to Overweight, JP Morgan said. Company is entering an important new product cycle. 
Bullish
Dec 17, 2013 | 8:01 AM EST
MDT was upgraded to Buy, Goldman Sachs said. $66 price target. Organic growth should accelerate over the next several quarters. 
Update
Dec 10, 2013 | 7:45 AM EST
Oppenheimer Healthcare Conference (Day 1 of 2) - 12/10/13 - 12/11/13 New York, NY
Bearish
Nov 20, 2013 | 8:22 AM EST
MDT was downgraded from Buy to Hold, Argus said. Sales have been softening for two quarters.   
Bullish
Nov 20, 2013 | 7:58 AM EST
MDT raised its numbers, Jefferies said. Recovery in ICDs and progress in key pipeline programs. $60 price target and Hold rating.
Bullish
Nov 20, 2013 | 7:50 AM EST
MDT estimates were raised through 2015, Leerink Swann said. New products can help boost growth. Market Perform rating and new $60 price...
Stock futures waver as quarterly retail results come in.

Columnist Conversations

The new Fed Chief said this at a recent meeting of the Economic Club of NY ... "We have indeed had a disappoin...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.